GI DYNAMICS, INC. (OTCMKTS:GIDYL) Files An 8-K Regulation FD Disclosure

Item7.01

On March29, 2017 EDT (which is March30, 2017 AEST), the Company
will provide a corporate presentation. The presentation is
currently available on the Companys website and furnished
herewith as Exhibit 99.1.

The information set forth in this Item 7.01, including Exhibit
99.1, is being furnished to Item 7.01 and shall not be deemed
filed for purposes of Section18 of the Securities Exchange Act of
1934, as amended (the Exchange Act), or otherwise subject to the
liabilities of that Section, and it shall not be deemed
incorporated by reference in any filing under the Securities Act
of 1933, as amended, or under the Exchange Act, whether made
before or after the date hereof, except as expressly provided by
specific reference in such a filing.

By filing this Current Report on Form 8-K and furnishing the
information in this Item 7.01, the Company makes no admission as
to the materiality of Item 7.01 in this report or the
presentation attached hereto as Exhibit 99.1. The information
contained in the presentation is summary information that is
intended to be considered in the context of the Companys filings
with the Securities and Exchange Commission (the SEC) and other
public announcements that the Company makes, by press release or
otherwise, from time to time. The Company undertakes no duty or
obligation to publicly update or revise the information contained
in this Item, although it may do so from time to time as its
management believes is appropriate. Any such updating may be made
through the filing of other reports or documents with the SEC,
through press releases or through other public disclosure.

The Company cautions you that the presentation attached hereto as
Exhibit 99.1 contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act, as
amended, including statements concerning: our development and
commercialization plans; our potential revenues and revenue
growth, costs, excess inventory, profitability and financial
performance, our cash runway; our ability to obtain reimbursement
for our products; our clinical trials, and associated regulatory
submissions and approvals; the number and location of commercial
centers offering the EndoBarrier; and our intellectual property
position.

These forward-looking statements are based on the current
estimates and expectations of future events by the management of
GI Dynamics, Inc. as of the date of this announcement and are
subject to a number of risks and uncertainties that could cause
actual results to differ materially and adversely from those
indicated in or implied by such forward-looking statements. These
risks and uncertainties include, but are not limited to: risks
associated with the consequences of stopping the ENDO Trial and
the possibility that future clinical trials will not be
successful or confirm earlier results; risks associated with
obtaining funding from third parties; risks relating to the
timing and costs of clinical trials, the timing of regulatory
submissions, the timing, receipt and maintenance of regulatory
approvals, the timing and amount of other expenses, and the
timing and extent of third-party reimbursement; risks associated
with commercial product sales, including product performance;
competition; risks related to market acceptance of products;
intellectual property risks; risks related to excess inventory;
risks related to assumptions regarding the size of the available
market, benefits of our products, product pricing, timing of
product launches, future financial results and other factors
including those described in our filings with the U.S. Securities
and Exchange Commission. Given these uncertainties, you should
not place undue reliance on these forward-looking statements.

See Exhibit Index attached hereto, which is incorporated by
reference herein.

GI DYNAMICS, INC. (OTCMKTS:GIDYL) Recent Trading Information

GI DYNAMICS, INC. (OTCMKTS:GIDYL) closed its last trading session 00.0000 at 0.0250 with 34,000 shares trading hands.